Structure/function analysis of the integrin beta 1 subunit by epitope mapping by unknown
Structure/Function Analysis of the Integrin/31 Subunit by 
Epitope Mapping 
Daw-Tsun Shih,* Jonathan M. Edelman,*~ Alan E Horwitz,§ Gerald B. Grunwald, II and 
Clayton A. Buck* 
*  Wistar Institute and ~  Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104; §  Department of 
Cell and Structural Biology, University of Illinois, Urbana, Illinois 61801; and II Department of Anatomy and Developmental 
Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 
Abstract.  Monoclonal antibodies (mAbs) have been 
produced against the chicken/3,  subunit that affect 
integrin  functions, including ligand binding,  ot subunit 
association,  and regulation of ligand specificity. Epi- 
tope mapping of these antibodies was used to identify 
regions of the subunit involved in these functions. To 
accomplish this,  we produced mouse/chicken chimeric 
81 subunits and expressed them in mouse 3T3 cells. 
These chimeric subunits were fully functional with re- 
spect to heterodimer formation,  cell surface expres- 
sion, and cell adhesion.  They differed in their ability 
to react with a panel of anti-chicken/~l  mAbs.  Epi- 
topes were identified by a loss of antibody binding 
upon substitution of regions of the chicken/3,  subunit 
by homologous regions of the mouse/31 subunit.  The 
identification of the epitope was confirmed by a 
reciprocal exchange of chicken and mouse fit domains 
that resulted in the gain of the ability of the mouse 
subunit to interact with a particular anti-chicken/31 
mAb.  Using this approach,  we found that the epitopes 
for one set of antibodies that block ligand binding 
mapped toward the amino terminal  region of the/31 
subunit.  This region is homologous to a portion of the 
ligand-binding  domain of the/~3 subunit. In addition,  a 
second set of antibodies that either block ligand bind- 
ing,  alter ligand specificity, or induce a//3 subunit dis- 
sociation mapped to the cysteine rich repeats near the 
transmembrane  domain of the molecule.  These data 
are consistent with a model in which a portion of/31 
ligand binding domain rests within the amino terminal 
200 amino acids and a regulatory domain, that affects 
ligand binding through  secondary changes in the struc- 
ture of the molecule resides in a region of the subunit, 
possibly including the cysteine-rich repeats, nearer the 
transmembrane  domain.  The data also suggest the 
possibility that the ot subunit may exert an influence 
on ligand specificity by interacting  with this regulatory 
domain of the/31  subunit. 
T 
HF. integrins  represent a family of receptors involved 
in both cell-matrix  and cell-cell adhesion (Albelda 
and Buck, 1990; Hemler,  1990; Hynes, 1992). They 
are heterodimers consisting  of an ot subunit non-covalently 
associated  with  a  /3  subunit.  Currently,  14  different  a 
subunits  and 8 different/~ subunits  (not including  alterna- 
tively  spliced  forms)  have  been described.  They join  in 
different combinations to form the 20 integrins presently rec- 
ognized in vertebrates. Each heterodimer forms a transmem- 
brane complex, its extracellular  domain interacting  with a 
ligand and its cytoplasmic domain interacting  with elements 
of the cytoskeleton. Integrin-ligand  interactions also serve to 
generate  intraceUular  signals  that  result  in  cytoplasmic 
alkalinization  (Schwartz et al.,  1991), protein phosphoryla- 
tion (Guan et al.,  1991; Kornberg et al.,  1991; Guan and 
Shalloway, 1992), changes in calcium influx (Ng-Sikorski  et 
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al., 1991; Pardi et al., 1989), and cell proliferation  (Shimizu 
et al., 1990). In addition,  integrin responses to second mes- 
sages result in changes ofligand specificity or affinity (Shattil 
et al.,  1985;  Tanaka et al.,  1992; Thornhill  et al.,  1991). 
Ligand binding and receptor activation are accompanied by 
conformational  changes in integrins  that result in new mAb 
binding  sites and  increased  ligand  affinity  (Coller,  1985; 
Frelinger et al.,  1990, 1991; Altieri and Edgington,  1988; 
Duet al., 1991). Thus integrins bind ligands, respond to in- 
tracellular  and  extracellular  signals,  coordinate  cytoskel- 
eton-membrane interactions,  and transmit information  into 
the cell resulting in changes in cell morphology and function 
(for review  see Hynes, 1992). 
To identify regions of the Bt subunit that may be involved 
in several of these functions,  we have mapped the epitopes 
of a panel of chicken fit-specific mAbs that interfere  with a 
particular integrin function using a series of mouse/chicken 
chimeric subunits.  The reagents  employed in these studies 
include mAbs that perturb cell-substratum interactions,  dis- 
rupt  subunit  association,  or affect  substratum  specificity. 
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Chimeric construct  Sequence  Rest. Enzy. Site 
MC- 1  S  5'-AAGCCGAGGCCTGCCGACACCGACCCGAGACCC-  3'  StuI 
AS  5'-AGCCAATTCGAAGTCTGAAGTAATCCTCCTCA-3'  AsuII 
MC-2  S  5'-CAGACTTTCGAATTGGCTTTGGC-  3'  AsuH 
AS  5'-TCACTAAGCTTCTGAACAAGGTG-3'  HindM 
MC-3  S  5'-GTTCAG.~GCTTAGTGAAAATAATAT-  3'  HindM 
AS  5'-ACTTGGGATCCGTGCACTTACAA-3'  Band-If 
MC-5  S  5'-CAGACTTTCGAATTGGCTTTGGC-3'  AsuH 
Mouse  AS  5'-ACTTCATCTGTGCTACATTCAC-3' 
Chicken  S  5'-GTGAATGTAGCACAGATGAAGT-3' 
AS  5'-TTTGGGATCCGTGCA-  3'  BamHI 
PCR primers used in the construction  of four chimeric chicken/mouse cDNAs are shown. For each construct the cloning restriction enzyme site within the primer 
is highlighted and the enzyme listed in the right column.  The complementary  sequences of the primer pair used for splice overlap extension in the construction 
of MC-5 are underlined.  S, sense primer; AS, antisense primer. 
Among the antibodies that perturb  cell substratum  interac- 
tions are CSAT (Neff et al., 1982) and JG22 (Greve and Gott- 
lieb, 1982), both of which have been extensively character- 
ized. It is assumed that these antibodies interact with regions 
of the receptor involved in ligand binding. Another antibody, 
TASC (Neugebauer and Reichardt,  1991), has the ability to 
block the binding of neuronal cells to vitronectin, and also 
to stimulate their adherence to laminin. This antibody is as- 
sumed, therefore, to interact with regulatory domains of the 
integrin/3~  subunit. 
Our  results  demonstrate  that  ligand-binding  activity  is 
blocked by mAbs that recognize epitopes widely separated 
on a linear amino acid map, and that there exist both ligand 
binding and regulatory regions that are distinct from one an- 
other. 
Materials and Methods 
Chimeric Plasmid Construction 
We have previously described the construction and expression of the full 
length cDNA clone for chicken/~l, pCINT/~RV (Solowska et al.,  1991). 
The chicken/31 cDNA was also cloned into the EcoRI site of the expres- 
sion vector, pCMV-5 (Anderson et al., 1988), provided by Drs. Gary Cohen 
and Rosalyn Eisenberg of the University of Pennsylvania (Philadelphia, 
PA), that had been modified to eliminate the cloning sites between Kpn 
I  and Sma I.  The resulting expression plasmid was designated pCMV- 
5CINT/~IRV. A 3.6-kb Hind HI cDNA fragment containing most ofthe coding 
region of the mouse/31 subunit in Bluescript (pBSM/~0 was kindly pro- 
vided by Dr. V. Michael Hollers of  Washington University (St. Louis, MO). 
PCR-directed mutagenesis  and  PCR-driven  splice  overlap  extension 
(SOE) l  (Horton  et  al.,  1990)  were  used  to  generate  five  chimeric 
mouse/chicken ~1 expression plasmids, designated MC-1  through MC-5, 
as described below. PCR reactions were performed in an automatic thermal 
cycler (Perkin-Elmer Cetus Instrs., Norwalk, CT).  Each 100/~1 reaction 
mixture included 10 mM Tris-HCl, pH 8.0, 1.5 mM MgCl2, 50 mM KC1, 
0.1% gelatin, 10% DMSO, 0.06% 2-mercaptoethanol, 200 mM each dNTP 
and 2.5 U of Taq DNA polymerase (Perkin-Elmer Cetus Instrs.). Reactions 
were cycled 25 times through a program that included incubations at 94°C 
for 1 rain, 56°C for 1 min, and 72°C for 2 rain. 
The primers used in the construction of each of the mouse/chicken chi- 
meric cDNAs are shown in Table  I. 
Construction of MCI. Primers were designed to amplify the mouse E1 
subunit from bp 1 to bp 627 and contained Stu I (sense primer) and Asu 
1. Abbreviations used in this paper:  RT-PCR, reverse transcription-PCR; 
SOE, splice overlap extension. 
II (antisense primer) sites at their 5' ends. Because pBSM/~I did not con- 
taln 395 bp of the 5' coding region, we used reverse mmscription-PCR (RT- 
PCR) to amplify this fragment. Total cellular RNA was isolated from 3"1"3 
cells by sequential extraction in RNAzol (Biotecx, Houston, TX) and chlo- 
roform, followed by isopropanol precipitation. 5 #g of total RNA was sub- 
jected to RT-PCR using the cDNA Cycle Kit (Invitrogen, San Diego, CA) 
according to the manufacturer's directions. First strand synthesis was ac- 
complished using random primers and reverse transcriptase. This strand 
was used as template in the standard PCR reaction. The RT-PCR product 
was gel purified using Gene Clean II glass beads (Bio !01) according to the 
manufacturer's directions and cut with Stu I and Asu II. pCINT~rRV was 
cut with Stu I and Asu 1I. The large piece of these digestion products was 
purified and ligated with the murine cDNA obtained above to yield the plas- 
mid pMC1. 
Construction OfMC2. PCR primers were designed to amplify the region 
of mouse/~t from bp 627 to bp 1077 of the cDNA and contained Asu II 
(sense primer) and Hind Ill (antisense primer) restriction sites at their 5' 
ends. Amplified DNA product was separated on a 1.0% agarose gel, visual- 
ized by ethidium bromide, purified, and digested with Asu II and Hind M. 
pCINT~tRV was cut with Asu II and Hind m  and the digestion products 
were separated on an agarose gel, and the larger piece was cut out and 
purified. This larger piece was then ligated with the amplified mouse ~1 
cDNA fragment. The resulting plasmid was designated pMC2. 
Construction of MC3. Primers were designed to amplify the region of 
mouse ~t  from bp  1077  to  1967  from the cDNA and contained Hind 
m  (sense primer) and BamI-I I (antisense primer) sites near their 5' ends. 
PCR product was purified and cut with Hind M  and BamH  I.  pCMV- 
5CINT/~IRV cut with Hind m  and BamH I was resolved on an agarose gel. 
The larger piece was purified and ligated with the mouse sequence obtained 
above. The resulting plasmid was designated pMC3. 
Construction of MC4. The plasmids pMC2 and pBSM/~I were digested 
with Tthlll I and Xho I and resolved on an agarose gel. The larger frag- 
ments from both digests were purified and ligated together. The resulting 
plasmid was designated pMC4. 
Construction OfMCS. PCR primers were designed to amplify the mouse 
~1 subunit from bp 627 to 1631 using mouse cDNA template and included 
an Asu II site at the 5' end of the sense primer. Additional primers were de- 
signed to amplify the chicken ~1 subunit from bp 1642 to 1980 using the 
chicken cDNA as template and included a BamI-I I site at the 5' end of the 
antisense primer. The mouse/~1 antisense and the chicken ~1 sense primers 
corresponded to a region that was identical between the species and were 
complementary to each other.  The amplified mouse and chicken cDNA 
fragments were mixed together and subjected to a further round of SOE in 
the presence of the mouse sense and chicken antisens¢ primers. The result- 
ing spliced mouse/chicken cDNA was cut with Asu II and BamH I and gel 
purified. The coding sequence between Asu H and BamH I of pMC1 was 
cut out and replaced with the spliced cDNA to yield the plasmid pMC5. 
Confirmation  of Chimeric cDNA Sequence.  The chimeric nature of 
each construct was confirmed by PCR  amplification using one mouse- 
specific and one chicken-specific primer. Constructs were also sequenced 
across the chimeric junction by the dideoxy nucleotide method to further 
validate the nature of the insert. 
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NIH 3T3 cells maintained in DMEM with 10% FBS were transfected as 
described previously  (Solowsks ct ai., 1989). Briefly, cells (105) plated the 
previous day in 100-ram dishes were cotranst~cted  with 10/~g of each chi- 
meric construct plasmid, 2 ~,g of pSV2-neo  and 10/~g of salmon sperm 
DNA as a calcium phosphate precipitate. After two days, the cells were split 
1:15 into DMEM with 10% FBS and 1 mg/ml Geneticin (00418, GIBCO 
BRL, Gaithersburg, MD). Approximately  2 wk later, G418 resistant clones 
were picked and screened for expression of the mouse/chicken chimeric B1 
subunit by immunoblot assay using the chicken specific polyclonai antibody, 
Chickie (see below).  The positive clones were further enriched by limited 
dilution subcloning and one clone of each construct was used for further 
characterization. 
Protein Labeling 
Cells were metabolically labeled by growing them overnight in methionine- 
free  media  supplemented with 250  t~Ci [35S]methionine.  Alternatively, 
cell-surface proteins were labeled with biotin. Briefly, confluent "I"25 flasks 
were washed with biotin washing buffer (50 mM Tris-HC1, pH 7.5, 150 mM 
NaC1, 1 mM MgCI2, 1 mM CaCI2) three times, and then labeled with 100 
t~g/ml NHS-sulfo-biotin (Pierce Chem. Co., Rock_ford, IL) in biotin wash- 
ing buffer for 30 rain at 37"C with gentle rocking. After labeling, flasks were 
washed three times in PBS and the cells extracted with non-ionic detergent 
buffer (10 mM Tris-Acctate, pH 7.5, 0.5% NP-40, 0.5 mM CaC12) contain- 
ing 2 mM PMSF for 20 rain at 4"C. Cell extracts were clarified by centrifu- 
gation at 14,000 g for 20 rain. 
Antibodies 
The following polyclonai  antisera were used: Lennie (L) and anti-GP140 
were raised in rabbit and goat, respectively,  against WGA affinity-purified 
extracts of rat L6A myoblasts and have been shown to react with a wide vari- 
ety of mammalian integrin/3t subunits, but have no reactivity with chicken 
B1 (Solowska et al.,  1991; Knudsen ct al.,  1981). Chickie (Ch) is a poly- 
clonai  rabbit  antibody  raised  against  the  chicken  integrin  molecule 
(Damsky et ai.,  1985) that has minimal cross reactivity with mammalian 
integrins. 
The  following  mAbs,  each reacting exclusively  with the chicken Bl 
subunit, were used: CSAT (Neff et ai.,  1982), JG22 (Greve and Gottlieb, 
1982), G (Buck et ai., 1986), 2AI0 (Chu and Grunwaid, 1991), and TASC 
(Nengebaner and Reichardt, 1991). The W1B10, V2E9, VSB8, VSF5, V9C3, 
and WlGll mAbs to the chicken El subunit were prepared from integrius 
purified on a CSAT mAb column using 11 day chicken embryos.  The prop- 
erties of W1BI0 and V2E9 have been described previously (Hayashi et al., 
1990).  Details about the mAbs are listed in Table H. 
Immunofluorescence 
Cells were plated in DMEM containing 2% FBS onto coverslips  coated 
with human plasma fibronectin (10 t~g/ml). After 24 h, cells were fixed for 
20 min with 3 % buffered paraformaldehyde and permeabilized with an ice- 
cold solution of 0.15 M NaC1 containing 1% NP-40 for 1 rain. The cover- 
slips were then incubated for 1 h at room temperature with the polyclonal 
anti-chicken  integrin  antibody, Ch, and a monoclonal anti-vinculin  antibody 
(Sigma Chem. Co., St. Louis, MO), washed, and stained for 1 h at room 
temperature with fluoreseein-conjugated  goat anti-rabbit IgG and rhoda- 
mine-eonjngated goat anti-mouse IgG (Organon Teknica, I/.oekville, MD). 
The cells were examined using a Zeiss phase-epi-fluorescent  microscope 
with 63 x  planachromat oil-immersion lens and photographed using Kodak 
Tri-X film. 
lmmunoprecipitation 
For immunoprecipitation, the nonionic detergent cell extracts were preab- 
sorbed with protein A-conjugated Sepharose (Pharmacia LKB Bioteehnol- 
ogy, Piscataway, NJ) for 30 rain at 4°C. One hundred mieroliters of this anti- 
gen solution were mixed with 50 #1 of antibody solution containing 1 #g 
of immunoglobulin for 18 h at 40C. Immune complexes were absorbed to 
protein A-conjugated Sepharose beads for 1 h at 4"C and were washed five 
times with a buffer containing 50 mM Tris HCI (pH Z5), 150 mM NaC1, 
1% Triton X-100, 5 % deoxycholate, and 0.1% SDS. For sequential immuno- 
precipitation the beads were suspended in 1% SDS, boiled for 5 rain, and 
the SDS diluted tenfold with 2.5% NP-40. The resulting released antigen 
was mixed with antibody and new protein A-Sepharose, and processed as 
described above. Immunoprecipitated complexes were then eluted in elec- 
trophoresis sample buffer (62.5 mM Tris base, 2% SDS, 10% glycerol, pH 
6.8) and electrophoresed through 6% polyacrylamide  gels. Biotinylated pro- 
teins were transferred from the gel to nitrocellulose paper using the Milli- 
Table II. mAbs Used 
mAb  Activity  Functional effect 
CSAT  (Neff et al.,  1982) 
JG22  (Greve and Gottlieb,  1982) 
2A10  (Chu and Grunwald,  1991) 
WlB10  (Hayashi et al.,  1990) 
V8B8  (unpublished observations) 
TASC  (Neugebauer and Reichardt,  1991) 
G  (Buck et al.,  1986) 
V2E9  (Hayashi et al.,  1990) 
V9C3  (unpublished observations) 
VSF5 
WlGll 
Immunoprecipitation (IP)  Inhibits fibroblast, myoblast 
IP  attachment to fibronectin 
(FN),  laminin (LN), and 
collagen (COL) 
Immunoblot  Inhibits retinal pigmented 
nonreduced (IB), IP  epithelial cell attachment 
to FN,  LN 
IB, IP  Inhibits fibroblast 
IB, IP  attachment to FN;  induces 
rounding of skeletal 
myoblasts 
IB, IP  Inhibits retinal neuron 
attachment to vitronectin; 
promotes retinal neuron 
attachment to LN and COL 
IB, IP  Disrupts c~B heterodimer 
formation 
IB, IP 
IB (also reduced),  IP 
IB, IP 
IB,  IP 
None 
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facturer's instructions. Biotinylated protein bands were detected by alkaline 
phosphatase conjugated-streptavidin (GIBCO BRL) using nitro blue tetra- 
zolium and 5-bromo--4-ehloro-3-indolyl phosphate (Sigma Chem. Co.) as 
substrate. [35S]methionine-labeled  protein containing gels were enhanced, 
dried, and exposed to X-omat film (Kodak). 
Cell Adhesion Assay 
Non-tissue culture 96 well plates were coated overnight with laminin (1 
#g/well) at 37"C, and then coated with 4% BSA in PBS for 1 h. Cells, la- 
beled with [3H]thymidine 24 h before use were trypsinized, washed three 
times in serum free DMEM, and plated at 5  ×  liP cells per well in the 
presence of specific antibodies. The cells were allowed to adhere for 2 h 
at 370C. Unattached cells were removed by gentle washing and the remain- 
ing cells were collected on a glass fiber filter using the Tomtec 96 well cell 
harvester. Filters were air dried and counted in a Packard Matrix 96 counter. 
Percent adherence was determined by dividing the counts remaining by the 
total counts plated per well, and normalized to the condition of no added 
antibody. Each value represents the average of at least four different mea- 
surements, and is shown with standard error of the mean. 
Results 
Mouse-Chicken Chimeric [3l cDNAs Encode 
Chimeric [31 Subunits, Associate with Endogenous 
Mouse ~ Subunits, and Are Expressed on the 
Cell Surface 
The chimeric/~ subunits used throughout these investiga- 
tions are schematically represented within each figure (e.g., 
Fig.  1 A). In all cases, within the schematic representation, 
the  filled portions represent chicken sequences and open 
areas represent mouse sequences. The various constructs are 
designated  C  for  chicken,  M  for  mouse,  and  MC  for 
mouse/chicken chimera. 
The accuracy of the cDNA constructs was determined by 
PCR analysis and sequencing (see Materials and Methods). 
In each case, the PCR analysis and subsequent sequencing 
data confirmed the position of the inserted mouse sequences 
as well as the fact that no changes in nucleotide sequence oc- 
curred during the production of  the chimeric cDNA (data not 
shown). 
Fig.  1 demonstrates the specificity of the anti-chicken/3, 
serum, the chimeric nature of each product, the association 
of each chimeric subunit with endogenous mouse ot subunits 
and the surface expression of each chimeric subunit. Fig.  1 
B shows that the chimeric subunits were found on the cell 
surface in association with mouse ~ subunits. To accomplish 
this, cell surface proteins were biotinylated, extracted with 
nonionic detergents, and subjected to immunoprecipitation 
followed by SDS-PAGE of the immuno complexes. The pair 
of SDS-PAGE lanes under the mouse schematic (M) shows 
the  results  of immunoprecipitating  aliquots  of an  extract 
from nontransfected 3T3 cells with the anti-mammalian/~t 
serum (L) and the anti-chicken/~t serum (Ch). The endoge- 
nous/~ integrins and accompanying ot subunits were read- 
ily identified by the anti-mammalian/~  serum but not by 
the anti-chicken/~ serum. In contrast, 3T3 cells transfected 
with full-length chicken ~  cDNA (C) or the three different 
mouse/chicken chimeric cDNAs (MC1, MC2, and MC3) all 
contained 110-120 kD B1 subunits that could be recognized 
by the anti-chicken ~1 serum, plus coprecipitating proteins 
of ,,o140 kD  representing  the  accompanying endogenous 
mouse  a  subunits.  Thus,  the  products  of the  transfected 
cDNAs all were recognized by the chicken-specific antise- 
rum, all paired with endogenous mouse ot subunits, and all 
were found on the cell surface. 
Fig. 1 Cillustrates the chimeric nature of  the protein prod- 
uct of each cDNA. Transfected 3T3 cells were labeled with 
[35S]methionine and extracted with NP-40. Each extract was 
first immunoprecipitated with the  anti-chicken /3,  serum, 
Ch. The immunoprecipitate was then dissociated with SDS 
and divided into two portions.  One was used directly for 
SDS-PAGE analysis and the other was reprecipitated with 
the anti-mammalian/~1  antibody, L.  The first set of lanes 
under the schematic (M)  representing endogenous mouse 
#~,  shows  a  typical immunoprecipitate of integrins  from 
3T3 cells. There are two non-specific bands noted, one in the 
vicinity of  the 205 kD marker and the other at ,,o8 kD, typical 
of metabolically labeled extracts. The two bands at 110 and 
120 kD represent the immature and fully glycosylated forms 
of the mouse ~1 subunit.  The bands above this represent a 
mixture of mouse ot subunits including o~3 and o~5 as shown 
previously (Solowska et al.,  1989).  No material was  spe- 
cifically immunoprecipitated from this extract by the anti- 
chicken /3~  antibody (Ch). The  second set  of controls is 
shown in the pair of lanes beneath schematic (C) represent- 
ing chicken/3~. The SDS-PAGE profile of the initial immu- 
noprecipitate (Ch) shows the immature (pre-/30, fully gly- 
cosylated  /~  bands  and  accompanying  a  subunits.  As 
expected,  the  anti-mammalian  /3~  antibody  (L)  failed  to 
reprecipitate any material. Similar immunoprecipitates from 
chimeric constructs are shown beneath each chimeric sym- 
bol (MC1, MC2, and MC3). In every case, material from the 
Chickie  immunoprecipitate  (Ch) could  be  reprecipitated 
with the antiserum that recognized mouse B, sequences (L). 
The immunoprecipitates in lanes designated L show only/3 
or pre-/~ bands and little if any associated a  subunit, as ex- 
pected for integrins reprecipitated after dissociation with a 
denaturing agent. As judged by these criteria, the subunits 
encoded by the constructs are indeed chimeric proteins. 
Chimeric [31 Subunits Localize to Focal Contacts and 
Promote CeU-Substratum Adhesion 
As  a  test  of the  functional  integrity  of the  chimeric  B~ 
subunits,  we evaluated their ability to localize in adhesive 
structures and to participate in cell-matrix adhesion. Trans- 
fected cells were plated onto coverslips coated with fibronec- 
tin, and 24 h later subjected to immunofluorescence analysis 
using  the anti-chicken #t  antibody.  Fig.  2  shows,  that  in 
each case, the chimeric protein was found concentrated in fo- 
cal contacts at the cell-matrix interface. That these were in- 
deed focal contacts was confirmed by the fact that vinculin 
was localized to the same structures by double immunofluo- 
rescence. 
The test for the ability of the chimeric subunits to promote 
cell adhesion was based upon the resistance of the chicken- 
mouse chimeric subunit to the adhesion disrupting activity 
of anti-GP  140,  a  polyclonal anti-mammalian  /~  subunit 
that has been previously used to perturb cell substratum 
adhesion  (Knudsen  et  al.,  1981;  Damsky  et  al.,  1982; 
Sutherland et al.,  1988). A  similar assay has been used to 
demonstrate the ability of chicken ~  subunits to promote 
adhesion in mammalian cells (Hayashi et al.,  1990; Solow- 
ska et al.,  1991).  For this purpose,  cells were plated on 
The Journal  of Cell Biology,  Volume 122, 1993  1364 Figure I. Immunochemical analysis of the products encoded by chimeric 131 cDNAs. (A) Schematic  representation of control and chimeric 
cDNA constructs.  Open areas correspond to mouse sequences.  Filled  areas correspond to chicken sequences.  Numbers correspond to 
amino acid residues bracketing inserted mouse cDNA fragments.  M, mouse; C, chicken; MC, mouse/chicken chimera. (B) Immunoprecipi- 
tates of  biotinylated  cell-surface protein extracts from 3T3 ceils expressing each construct are shown in SDS-PAGE lanes beneath the corre- 
sponding schematic symbol. Extracts from untransfected  cells were immunoprecipitated with anti-mammalian/31  (L) or anti-chicken 131 
(Ch) antibodies.  The positions of integrin a  and/3 subunits  are designated on the right.  The position of each Mr standard in kD is shown 
on the left.  The data in the first two lanes represent immunoprecipitation of nontransfected  3T3 cells  with both antibodies.  These lanes 
show immunoprecipitation of integrin  complexes (Mr 110-200) by L but not by Ch establishing  the specificity  of the antibodies  with re- 
spect to endogenous/31  integrins.  The extracts  containing intact chicken or chimeric/31  subunit protein reveal surface-expressed  integrin 
heterodimers.  (C) Metabolically labeled extracts  from 3T3 cells expressing  wild-type or chimeric constructs were immunoprecipitated 
with the anti-chicken/31  antibody (Ch). One half of the immunoprecipitate was dissociated with SDS and reprecipitated  using the anti- 
mammalian  /31  antibody  (L).  Both  precipitates  were  resolved  on  SDS-PAGE  gels.  Results  are  shown  beneath  the  corresponding 
schematics.  The arrow beneath the lanes indicates  sequential  immunoprecipitation. The positions  of integrin ct, pre-/3, and/3 subunits are 
designated on the right.  The pre-/3 subunit is the bottom band encompassed by the bracket. While all of the transfected  cell extracts showed 
reactivity with Ch, only the chimeric subunits  showed immunoreactivity with the anti-mammalian/31  antibody on reprecipitation  (MC1, 
MC2, and MC3). 
dishes coated with laminin in the absence of blocking anti- 
body or in the presence of either anti-GP140, CSAT, or anti- 
GP140 plus CSAT. The control cells used in this experiment 
were 3T3 cells transfected with full length chicken 131 cDNA 
(C) or with cDNA encoding a  chicken/31  subunit missing 
the cytoplasmic domain (AC), and hence unable to promote 
cell-matrix adhesion, but capable of binding the CSAT rnAb 
(Solowska et al.,  1989).  While CSAT alone had little or no 
effect on the ability of any of the cells to adhere to laminin, 
anti-GP 140 reduced adhesion of  the AC cells by ,'o90% indi- 
caring that adhesion was mediated by integrins containing the 
mammalian 131 subunit.  In contrast,  cells expressing the in- 
tact  chicken  131  subunit  or  the  chimeric  mouse/chicken 
subunits remained adherent even in the presence of anti-GP 
140.  Furthermore,  exposure of C,  MC2, and MC3 cells to 
both anti-GP 140 and CSAT prevented adhesion of 80-90% 
of the cells.  However, ,x60 % of MC1 cells remained adher- 
ent when CSAT was added to anti-GP140, suggesting a loss 
Shih et al. lntegrin  131 Epitopes Reveal Functional Domains  1365 Figure 2. Chimeric/31 subunits are found in focal contacts and participate in cell-substratum adhesion. Transfected 3T3 cells were plated 
onto coverslips coated with fibronectin and stained with a mixture of rabbit anti-chicken 131 polyclonal antibody and mouse anti-vinculin 
mAb. The coverslips were counterstained with fluorescein-conjugated goat anti-rabbit IgG and rhodamine-conjugated goat anti-mouse 
IgG. The photomicrograph pairs in each row depict cells expressing the construct indicated (MC1, MC2, and MC3) or control 3T3 cells 
transfected with a  cytoplasmic deficient mutant of chicken/31 (AC) or full-length chicken/31  (C).  Cells in the left column were pho- 
tographed to  show the chicken/~1  staining (fluorescein). The  identical preparation was photographed to  show the vinculin staining 
(rhodamine) in the central column. Arrows designate typical focal contacts showing both fluorescein and rhodamine staining. Arrowheads 
in the first pair of micrographs (AC) show rhodamine-stained focal contacts that contain no fluorescein staining, despite the fact that the 
cytoplasm of this cell is brightly fluorescent. Arrowheads in the photomicrographs of MC2 show the appearance of rhodamine-, but not 
fluorescein-stained focal contacts in an untransfected cell further indicating the specificity of the Ch antibody for only those focal contacts 
containing subunits with chicken sequences. The right column shows antibody inhibition of adhesion of control and transfected cells labeled 
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for four representative mAbs. 
Immunoprecipitations  using 
the indicated  monoclonal  anti- 
chicken  8~  antibodies  of 
surface-biotinylated  control 
and transfected  3"1"3 cell ex- 
tracts were subjected to SDS- 
PAGE, transferred  to  nitro- 
cellulose,  and  developed  as 
described  in  Materials  and 
Methods.  The  results  are 
shown beneath the schematic 
of each construct. M, Mouse; 
C,  Chicken;  MC,  Mouse/ 
Chicken chimera. Open por- 
tions of symbols designate the 
position of mouse sequences; 
filled  portions  designate 
chicken sequences. The mAbs 
used for immunoprecipitation 
are shown at the left of each 
set  of  SDS-PAGE  lanes. 
Where  more  than  one  anti- 
body is specified,  the results 
for each antibody were identi- 
cal. The positions of c~ and 8 
subunits  are shown at the right 
of each set of lanes; Mr stan- 
dards in kD are shown on the 
left. Biotinylated  mouse inte- 
grins were present in extracts 
of control 3T3  ceils  (M)  as 
shown in Fig. 1. mAbs with no 
known biological activity are 
italicized. 
with tritiated thymidine and plated in laminin-coated  wells in the absence of antibody (filled bars); in the presence of CSAT (hatched bars), 
in the presence of an anti-mammalian  8, subunit antibody (anti-GP140;  stippled  bars),  or CSAT plus anti-GPl40 (open  bars).  Control 
adhesion in the absence of added antibody was normalized  to 100%. Note the resistance of all cells except for control (AC) to the adhesion 
disrupting effects of the anti-mammalian  8~ antibody, and the requirement for both antibodies for maximum inhibition  of adhesion of cells 
transfected  with chicken 81, MC2, and MC3, but not MC1 cDNA. See text for details. 
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3). Finally, the fact that MC1, MC2, and MC3 remain adher- 
ent in the presence of anti-GP140 suggests that the adhesion 
disrupting epitope recognized by this polyclonal antiserum 
is absent in all three chimeric subunits.  The chicken se- 
quence that is common to these three subunits contains the 
epitope  for  another  adhesion blocking  mAb,  WlB10,  as 
shown in Fig. 3. These results demonstrate that all the chi- 
meric constructs actively promoted the adhesion of the cells 
to laminin. 
The Epitopes  for Adhesion Perturbing  and 
Function Altering mAbs Map to Distinct Regions of 
the [31 Subunit 
The epitope mapping presented here takes advantage of the 
fact that each of the mAbs used reacts only with the chicken 
/3~ subunit. Therefore, the ability of any of these mAbs to 
recognize a  chimeric mouse/chicken subunit requires the 
presence of the appropriate chicken peptide sequence folded 
into its native configuration. Since integrin function is easily 
disrupted  as  a  result  of genetic  manipulation of subunit 
cDNA, the interpretation of these experimental results is de- 
pendent upon the functional integrity of the subunit under 
investigation (for review see Buck et al., 1990).  The above 
experimental results suggest that the chimeric subunits main- 
tained their functional integrity, and that the failure of any 
mAb  to  react  with a  particular  mouse/chicken chimeric 
subunlt should be due to replacement of the chicken se- 
quence by the homologous mouse sequence, and not due to 
secondary  structural  alterations in  the  chimeric  subunit. 
Therefore, loss of antibody reactivity constitutes evidence 
that at least a portion of the binding site for the particular 
mAb in question is within the replaced region of the mol- 
ecule. 
Chimeric constructs were prepared in which chicken se- 
quences  were  systematically  replaced  with  homologous 
mouse sequences between residues 1 and 602. The inserted 
mouse sequences ranged in  size from 140 to 300 amino 
acids. Typical data for four different mAbs are presented in 
Fig. 3. Of the four mAbs used here, three disrupt cell sub- 
stratum adhesion (CSAT, 2A10, and W1B10) and one blocks 
chicken cell adhesion to vitronectin but promotes adhesion 
to laminin (TASC).  Transfected and control cells were bi- 
otinylated, extracted with NP-40, and the extracts immuno- 
precipitated  with each of the mAbs.  Immunoprecipitates 
were analyzed by SDS-PAGE.  The  SDS-PAGE  profile of 
each construct is shown below its respective schematic pre- 
sentation.  All mAbs grouped together in Fig.  3  gave  the 
same immunoprecipitation profiles,  mAbs with no known 
biological activity are italicized. 
Three of the mAbs that block cell substratum adhesion, 
CSAT, JG22,  and V8B8  failed to immunoprecipitate chi- 
meric subunit MC1 in which the first 160 amino acids of the 
chicken subunit were replaced by the homologous region 
from the mouse subunit. They did, however, immunoprecip- 
itate each subunit in which the first 160 amino acids was 
chicken, suggesting that part of  the epitope for these antibod- 
ies resides in this region of the molecule. 2A10,  another 
adhesion-perturbing mAb, could only precipitate MC3, indi- 
cating that the epitope for this mAb resides on both sides of 
amino acid 160 of the chicken subunit. The fact that both the 
MC1 and MC2 chimeric subunits contained chicken amino 
acid sequences from residues 602 to 779 indicates that the 
epitope for 2A10 does not lie in this region of the molecule. 
Interestingly, the integrin activating l'nAb TASC could im- 
munoprecipitate all the chimeric subunits with the exception 
of MC3. This suggests that the epitope for this mAb resides 
between amino acids 304 and 602. The epitopes for several 
other mAbs also mapped to this region of the/~, subunit. 
These  include the  mAb  "G; which has  been previously 
shown to disrupt or/3 subunit association (Buck et al., 1986), 
as well as several mAbs with no known biological activity. 
The mAb WIB10 is capable of disrupting cell-substratum 
adhesion. The epitope for this antibody, however, appears to 
rest outside the region of the subunit carrying the epitopes 
for other adhesion-disrupting rnAbs. This mAb immunopre- 
cipitated all the chimeric constructs. The only chicken se- 
quence that is common to all of the chimeric subunits lies 
between residues 602 and 779.  It is reasonable to assume 
that the antibody cannot react with residues  709  to 779 
which include the transmembrane and cytoplasmic domain 
sequences of the subunit.  At least part of the epitope for 
W1B10 must, therefore, rest between residues 602 and 709. 
The observation that MC1,  MC2, and MC3 resist detach- 
ment by the anti-GP140 mammalian ~  antiserum and in 
particular that MC1 is largely resistant to detachment by the 
combination of anti-GP140 and CSAT (Fig. 2), suggest that 
this polyclonal antibody is  reacting primarily against the 
mouse homologue of the epitope seen by W1B10. 
Insertion of  Homologous Regions of the 
Chicken [31 cDNA into the Mouse Subunit Confers 
Chicken Specific mAb Binding to the 
Chimeric Subunit 
To confirm the location of two regions identified as antibody 
binding epitopes by the  loss-of-binding studies described 
above, we tested two reciprocal constructs for the acquisition 
of mAb-binding activity. To accomplish this, we placed the 
chicken cDNA coding for the CSAT- or TASC-binding do- 
mains into the homologous regions of the mouse/~1 sub- 
unit. The sequences carrying the epitopes for these mAbs 
were chosen for two reasons. First, each antibody has dis- 
tinctly different effects on integrin function. Second, their 
epitopes mapped to distinct regions of the molecule (i.e., 
CSAT epitope within the first 160 amino acids; TASC epi- 
tope within the cysteine-rich repeats, from amino acids 304 
to 602).  The two constructs are illustrated in Fig. 4.  As 
would be predicted, MC4, in which the first 160 mouse se- 
quences were replaced by chicken sequences,  reacts with 
CSAT but not TASC.  On the other hand, MC5, in which 
amino acids 493-779 are chicken, reacted with TASC, but 
not with CSAT. The fact that TASC did not react with MC3, 
which contains chicken sequence between amino acids 602 
and 779,  further limits its epitope to between amino acids 
493 and 602. These experiments confirm the location of the 
epitopes and demonstrate that the loss of  rnAb-binding activ- 
ity in the other chimeric subunits was not caused by second- 
ary structural changes. 
Discussion 
To facilitate interpretation, the data presented here are sche- 
matically  summarized  in  Fig.  5.  The  region  of the  /3, 
subunit homologous to the suggested ligand-binding domain 
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/~t eDNA.  The regions of chicken/31 cDNA carrying  either  the 
CSAT epitope (MC4) or the TASC epitope (MC5) were substituted 
into the homologous position on mouse 151 cDNA.  The resulting 
constructs  were transfected  into  3T3 ceils.  The transfected  cells 
were  biotinylated  and  extracted  as  described  in  Materials  and 
Methods.  The extracts  were  immunoprecipitated  with  CSAT or 
TASC as shown in the figure. Antibodies are listed as described in 
Fig. 3. In both cases, the substitution of the appropriate chicken se- 
quence resulted in the chimeric subunit being immunoprecipitated 
by the corresponding  mAbs. 
of/33  is  indicated  by shading.  A  19-amino acid  sequence 
within  this  region  that  is  highly  conserved  among  all  /3 
subunits is depicted as a solid bar. The cysteine residues that 
are homologous with those cross-linked in the f13 subunit to 
form two long-range disulfide bonds (Calvete et al.,  1991; 
Beer and Coller, 1989) are connected by lines. These include 
the first cysteine (C1) occupying position 7 paired with the 
16th cysteine (C16) occupying position 445, and the 14th cys- 
teine  (C14)  at position 415  paired with  the  54th  cysteine 
(C54) at position 672. Regions of the subunit bearing the epi- 
topes for the various mAbs investigated here are bracketed 
by  arrows.  Numbers  of  important  reference  amino  acid 
residues are indicated above the bar. 
Integrin-ligand binding  and ligand  specificity can be al- 
tered as a result of long range structural perturbations by an- 
tibodies or by intracellular signals (Coller,  1985;  Shattil et 
al.,  1985;  Brass and  Shattil,  1987;  O'Toole et al.,  1990; 
Frelinger et al.,  1991;  Frojmovic et al.,  1991;  Sims et al., 
1991; Chen et al., 1992; discussed in Ginsberg et al., 1992). 
The assignment of functional domains to an integrin subunit 
on the basis of epitope mapping, mutational analysis, dele- 
tion analysis or functional analysis of intersubunit chimeras 
must therefore take into account the possibility that any al- 
terations in integrin function or, in this case, antibody bind- 
ing, could be the result of secondary changes at other regions 
of the molecule. We therefore confirmed that the chimeric 
subunits under investigation here were fully functional and 
that the interchange of mouse and chicken domains did not, 
to the best of our knowledge, induce subtle secondary altera- 
tions in the structure.  The chimeric/~1 subunits paired with 
subunits, were found on the cell surface, localized in adhe- 
sion  plaques,  and  functioned  as  part of the  cell-adhesive 
mechanism. In addition, the effects of mAb binding on sub- 
stitution of mouse sequences into homologous regions of the 
chicken  /~  subunit  were position  specific and  reciprocal. 
That is, if the substitution of a particular mouse domain on 
the chicken subunit resulted in loss of antibody-binding ac- 
N 
CSAT 
V8B8 
JG22  2A10 
415 iC14)  672 (i54) 
~  67  160  212  493  602  709  779 
i| 
C 
7 ( C1 )  445 ( C16 )  TASC  W1B10 
G 
Figure 5. Linear schematic summary of epitopes for function-altering mAbs. The regions carrying the epitopes for each set of rnAbs are 
bracketed  by arrows. Relevant amino acid residue numbers are indicated along the top of the bar. Proposed  long range disulfide bonds 
are joined linearly with the paired cysteines being designated at the ends of each line. Four cysteine rich repeats, C, are designated within 
the bar. Shaded and solid areas represent  regions homologous to ligand-binding sites on the/~3 subunit as described  in the text. 
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mouse  /5~  subunit  with  chicken  amino  acid  sequences 
resulted in the acquisition of antibody reactivity. 
Because of the apparent structural "plasticity" of integrin 
subunits,  the  assignment of functional domains  based 
solely on genetic manipulations may be misleading. There- 
fore, correlation of genetic analysis with direct chemical or 
physical determinations of molecular interactions greatly 
strengthens these  structure/function assignments.  The as- 
signment of the ligand-binding domain of the /51  subunit 
within the first 200 amino acid residues is consistent with 
several lines of evidence derived from independent analyses. 
Studies in which RGD-containing peptides have been chemi- 
cally cross-linked to platelet c~libl~3 (D'Souza et al.,  1988) 
and  the  related  vitronectin  receptor,  c~d53 (Smith  and 
Cheresh, 1988), have identified a homologous region within 
the  first 250  amino  acid residues  of the  /53  subunit as  a 
ligand-binding domain. Antibodies raised against the highly 
conserved sequence within this series of amino acid residues 
(see Fig. 5) can block ligand binding (Andrieux et al., 1991). 
A single amino acid substitution at position 119 within this 
region renders a~3  incapable of ligand binding (Loftus et 
al.,  1991). A similar mutation in the homologous position 
of the /51  subunit also prevents ligand binding (Takada  et 
al.,  1992). 
The epitopes  for other adhesion perturbing  antibodies, 
WlB10 and TASC map between residues 493 and the trans- 
membrane domain of the subunit, placing them almost at the 
opposite end of  the extracellular portion of the molecule. Be- 
cause there are  no data implicating this region of any /5 
subunit with direct ligand binding, we favor the idea that the 
activity of  these mAbs is the result of their binding to regula- 
tory domains of the subunit. The interaction of mAbs with 
such domains would change the ligand-binding potential of 
integrins even though the epitopes for these antibodies reside 
outside the actual ligand-binding site. In this case, antibody 
binding would result in the integrin losing its ability to recog- 
nize one ligand, and gaining the ability to bind another. This 
proposal is consistent with what is known concerning the 
effect of antibodies or ligand binding on the t53 subunit. The 
binding  of mAbs  or  RGD-containing peptides  to  the  /53 
subunit will, by themselves, causes activation of ~b~3 and 
increased ligand affinity (O'Toole et al.,  1990;  Frelinger et 
al., 1991; Frojmovic et al., 1991). Similar examples of anti- 
bodies modifying the activity of integrins carrying the/51 
subunit have been documented. One stimulates the binding 
of c~4/5~ on a  myelomonocytic cell line to cells expressing 
recombinant VCAM-1 (Kovach et al.,  1992).  A second in- 
duces modification  of ligand affinity  on the fibronectin recep- 
tor o~5/51 (Faull et al.,  1993).  A third antibody changes the 
ligand specificity of a2/3~ to include both collagen and lami- 
nin (Chan and Hemler, 1993).  The epitopes for these anti- 
bodies have not been identified, but likely reside in domains 
of the subunit that could be considered regulatory in nature. 
Assuming the  mAb  TASC  and the  ligand blocking rnAb 
W1B10 define such regulatory domains in the /51  subunit, 
our data would suggest that these domains will be found in 
the disulfide-rich region near the transmembrane domain of 
subunits. Interestingly, the epitope for the mAb G, which 
dissociates c~//~ heterodimers, also maps to this region of 
the molecule. This raises the possibility that the ot subunit 
could influence ligand specificity both by providing part of 
the structure of the actual Iigand-binding domain (D'Souza 
et al.,  1990)  and by causing secondary changes in the/51 
subunit  through  interactions  outside  the  actual  ligand- 
binding  site.  This  might  help  assure  the  ligand-binding 
specificity or affinity of integrins sharing a promiscuous 
subunit such as Otv, that, depending upon the/3 subunit with 
which it associates, can bind to one or more ligands. 
In summary, the epitope mapping data presented here are 
consistent with the idea (a) that the ligand-binding domain 
of the/51 subunit is found within the first 200 amino termi- 
nal residues; (b)  that there is a regulatory domain located 
more carboxy terminal between residue 493 and the trans- 
membrane domain; and (c) that o~ subunit interactions may 
involve sequences also within this regulatory domain. 
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